P
LIVE

Serial Number

98512343

Owner

PRIME THERAPEUTICS LLC

Attorney

Felicia J. Boyd

Filing Date

Apr 22, 2024

Add to watchlist:

No watchlists yet
View on USPTO

P Trademark

Serial Number: 98512343

P is a trademark filed by PRIME THERAPEUTICS LLC on April 22, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 39 (Transportation & Storage), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

PRIME THERAPEUTICS LLC (46 trademarks)

2900 Ames Crossing Road, Suite 200
Eagan, MN 55121

Entity Type: 03

Trademark Details

Filing Date

April 22, 2024

Registration Date

Not Registered

Published for Opposition

April 8, 2025

Goods & Services

Providing educational information, online, non-downloadable articles, online, non-downloadable videos, and supporting materials in the nature of online, non-downloadable brochures in the field of the academic study of pharmaceuticals and the academic study of treatment of medical conditions for academic purposes; providing a website featuring educational information, online, non-downloadable articles, online, non-downloadable videos, and supporting materials in the nature of online, non-downloadable brochures in the field of the academic study of pharmaceuticals and the academic study of treatment of medical conditions for academic purposes

Downloadable mobile applications for reviewing medical and prescription drug benefits and coverage, reviewing prescription drug utilization and spending, managing drug prescriptions, managing drug prescription purchase and delivery options, accessing educational information on prescription drugs, finding a pharmacy, finding prescription drug pricing, comparing prescription drug pricing, receiving notifications on prescription drug pricing and savings, and tracking prior authorizations for prescription drugs

Delivery of goods; distribution services, namely, delivery of pharmaceuticals

House mark for a full line of pharmaceuticals

Pharmacy benefit management services

Medical cost management; medical cost management in the field of pharmaceuticals; pharmaceutical and medical formulary management in the nature of providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for pharmaceutical and medical formula approval; prescription drug utilization review services; healthcare utilization review services; pharmaceutical cost management services; medical cost management services in the field of home delivery of prescription drugs; providing business intelligence services in the field of pharmacy benefit management; business services provided to the healthcare industry, namely, the collection, reporting, and analysis of data pertaining to pharmaceuticals and consumer behavior for business purposes; providing business management information in connection with consulting and advisory services to the healthcare industry in the fields of prescription drug savings and reducing out-of-pocket costs and expenses for prescriptions; medical cost management consulting in the field of prescription drug therapies, specifically, site of care and administration of prescription drugs; business administration services, namely, negotiating contracts with prescription drug manufacturers to enable participant members of pharmacy benefit management clients to obtain discounts and rebates on pharmaceuticals; administration of a pharmacy discount program for enabling participants to obtain discounts on prescription drugs; administration of a discount program for enabling participants to obtain discounts on prescription drugs through the use of a discount membership card; Providing a website featuring business information in the field of office space configuration and remote work; Retail pharmacy services; mail order pharmacy services; pharmaceutical services, namely, processing and the coordination of the delivery of online and telephone prescription orders in retail, mail order and central fill pharmacies

Medical and pharmaceutical consultation; pharmaceutical advice; dispensing of pharmaceuticals; providing educational information in the field of medical information regarding pharmaceuticals and treatment of medical conditions; providing a website featuring educational information in the field of medical information regarding pharmaceuticals and treatment of medical conditions

Software as a service (SaaS) services featuring software for reviewing medical and prescription drug benefits and coverage, reviewing prescription drug utilization and spending, managing drug prescriptions, managing drug prescription purchase and delivery options, accessing educational information on prescription drugs, finding a pharmacy, finding prescription drug pricing, comparing prescription drug pricing, receiving notifications on prescription drug pricing and savings, and tracking prior authorizations for prescription drugs

Filing History

TEAS STATEMENT OF USE RECEIVED
Oct 14, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 3, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 8, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 8, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 2, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 11, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 11, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 11, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 11, 2025 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 10, 2025 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 4, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 21, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 21, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 21, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 21, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 21, 2025 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 6, 2025 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 10, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 19, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 19, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 19, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 19, 2024 CNEA
ASSIGNED TO EXAMINER
Nov 5, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 9, 2024 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 9, 2024 NWOS
NEW APPLICATION ENTERED
Apr 22, 2024 NWAP